8-K

Company

Summit Therapeutics Inc.

Filed

July 18, 2022

Period of Report

July 18, 2022

Accession Number

0001599298-22-000080

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →